Work

Effect of short‐acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double‐blind placebo‐controlled trial

Year: 2020

Type: article

Source: Diabetes Obesity and Metabolism

DOI: 10.1111/dom.14078

Authors: Nicklas J. Johansen, Thomas F. Dejgaard, Asger Lund, Camilla Schlüntz, Emil L. Larsen, Henrik E. Poulsen, Jens P. Goetze, Holger J. Møller, Tina Vilsbøll, Henrik U. Andersen, Filip K. Knop

Institutions: University of Copenhagen, Gentofte Hospital, Steno Diabetes Center Copenhagen, Bispebjerg Hospital, Rigshospitalet, Aarhus University Hospital, Novo Nordisk Foundation Center for Basic Metabolic Research

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Steno Diabetes Center Copenhagen, Novo Nordisk Fonden

Awards: G1630305306, G2790715585, G7296617283

OpenAlex ID: W3034650271

FWCI: 0.566

Cites: 43

Cited by: 13

Related to: 10